Sumitomo Mitsui Ds Asset Management Company, LTD Regeneron Pharmaceuticals, Inc. Transaction History
Sumitomo Mitsui Ds Asset Management Company, LTD
- $7.99 Billion
- Q1 2024
A detailed history of Sumitomo Mitsui Ds Asset Management Company, LTD transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Sumitomo Mitsui Ds Asset Management Company, LTD holds 13,268 shares of REGN stock, worth $13.9 Million. This represents 0.16% of its overall portfolio holdings.
Number of Shares
13,268
Previous 12,811
3.57%
Holding current value
$13.9 Million
Previous $11.3 Million
13.5%
% of portfolio
0.16%
Previous 0.15%
Shares
27 transactions
Others Institutions Holding REGN
# of Institutions
1,426Shares Held
82.1MCall Options Held
835KPut Options Held
1.46M-
Vanguard Group Inc Valley Forge, PA8.93MShares$9.33 Billion0.17% of portfolio
-
Black Rock Inc. New York, NY8.57MShares$8.95 Billion0.19% of portfolio
-
Jpmorgan Chase & CO New York, NY7.73MShares$8.07 Billion0.68% of portfolio
-
State Street Corp Boston, MA4.84MShares$5.06 Billion0.21% of portfolio
-
Capital World Investors Los Angeles, CA4.65MShares$4.86 Billion0.76% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $112B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...